Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07VEW
|
|||
| Former ID |
DNC000512
|
|||
| Drug Name |
DADMe-ImmG
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H17N5O3
|
|||
| Canonical SMILES |
C1C(C(CN1CC2=CNC3=C2N=C(NC3=O)N)O)CO
|
|||
| InChI |
1S/C12H17N5O3/c13-12-15-9-6(1-14-10(9)11(20)16-12)2-17-3-7(5-18)8(19)4-17/h1,7-8,14,18-19H,2-5H2,(H3,13,15,16,20)/t7-,8+/m1/s1
|
|||
| InChIKey |
GSPTUGDLYPMLCQ-SFYZADRCSA-N
|
|||
| CAS Number |
CAS 548486-61-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J Biol Chem. 2003 Aug 22;278(34):31465-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.